GCP
CALA

GSA Capital Partners’s Calithera Biosciences, Inc CALA Stock Holding History

GSA Capital Partners’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,128
Closed -$33K – 1962
2022
Q1 		$33K Sell
4,128
-10,530
-72% -$108K ﹤0.01% 1350
2021
Q4 		$195K Sell
14,658
-11,625
-44% -$292K 0.02% 1238
2021
Q3 		$1.15M Buy
26,283
+20,877
+386% +$901K 0.12% 240
2021
Q2 		$226K Buy
5,406
+4,877
+922% +$214K 0.03% 1123
2021
Q1 		$26K Sell
529
-194
-27% -$11.3K ﹤0.01% 1046
2020
Q4 		$71K Sell
723
-7,042
-91% -$617K 0.01% 1125
2020
Q3 		$536K Buy
7,765
+5,595
+258% +$488K 0.09% 349
2020
Q2 		$229K Buy
+2,170
New +$258K 0.13% 281
2018
Q2 		– Sell
-4,063
Closed -$512K – 2018
2018
Q1 		$512K Buy
+4,063
New +$634K 0.03% 1049
2017
Q4 		– Sell
-1,513
Closed -$477K – 1903
2017
Q3 		$477K Sell
1,513
-2,555
-63% -$806K 0.03% 1001
2017
Q2 		$1.21M Buy
4,068
+2,651
+187% +$709K 0.08% 419
2017
Q1 		$327K Buy
+1,417
New +$245K 0.02% 1330
2016
Q3 		– Sell
-2,190
Closed -$162K – 2041
2016
Q2 		$162K Buy
2,190
+450
+26% +$45.1K 0.01% 1618
2016
Q1 		$198K Buy
+1,740
New +$197K 0.01% 1496

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSA Capital Partners's CALA Position: Q2 2022 in Review

GSA Capital Partners sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 4,128 shares — an estimated $33K sold.

GSA Capital Partners first reported a position in CALA in Q1 2016 and held it in 14 quarters. The position peaked at $1.21M in Q2 2017. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • GSA Capital Partners reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • GSA Capital Partners sold 4,128 Calithera Biosciences, Inc shares in Q2 2022, an estimated $33K.
  • GSA Capital Partners first reported a position in Calithera Biosciences, Inc in Q1 2016 and held it in 14 quarters.
  • GSA Capital Partners's Calithera Biosciences, Inc position peaked at $1.21M in Q2 2017.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.